The FDA's guidance on blood donor eligibility focuses primarily on medications that could pose risks to recipients or indicate underlying conditions that would disqualify donation
Skeletal Muscle Loss: Cachexia, Sarcopenia, and Inactivity. The American Journal of Clinical Nutrition , vol
Minimally invasive solutions
The gradual titration from 0.25 mg to maximum doses over four to five months gives your body time to adjust while building toward the therapeutic levels that produce significant weight loss
The SURMOUNT-1 trial (N=2,539), published in the New England Journal of Medicine in 2022 (DOI: 10.1056/NEJMoa2206038), evaluated tirzepatide at 5mg, 10mg, and 15mg weekly doses versus placebo in adults with obesity or overweight
If youre taking diabetes medications, please discuss this with your prescribing doctor before starting Wegovy, as your diabetes medications may need to be adjusted as you lose weight